Search

Uribe-Leitz, Tarsicio, Alejandra Barrero-Castillero, Arturo Cervantes-Trejo, Jose Manuel Santos, Alberto Rosa-Rabago, Stuart Lipsitz, Maria Antonia Basavilvazo-Rodriguez, Neel Shah, and Rose Molina. 2019. “Trends of Caesarean Delivery from 2008 to 2017, Mexico”. Bull World Health Organ 97 (7): 502-12.

Shah, Neel, and Leanna Sudhoff. 2019. “In Reply”. Obstet Gynecol 134 (1): 180-81.

Lenti, Gena, Allison Norenberg, Jeanne Farnan, Arlene Weissman, Michelle Cook, Neel Shah, Christopher Moriates, et al. 2019. “Development and Testing of a Web Module to IMPROVE Generic Prescribing of Oral Contraceptives Among Primary Care Physicians”. J Clin Pharm Ther 44 (4): 579-87.

Shah, Neel, Kelly Wright, Gudrun Jonsdottir, Selena Jorgensen, Jon Einarsson, and Michael Muto. 2011. “The Feasibility of Societal Cost Equivalence Between Robotic Hysterectomy and Alternate Hysterectomy Methods for Endometrial Cancer”. Obstet Gynecol Int 2011: 570464.

Moriates, Christopher, Neel Shah, and Vineet Arora. 2014. “Primary Nonadherence With Prescribed Medication”. Ann Intern Med 161 (9): 678.

Gourevitch, Rebecca, Ateev Mehrotra, Grace Galvin, Melinda Karp, Avery Plough, and Neel Shah. 2017. “How Do Pregnant Women Use Quality Measures When Choosing Their Obstetric Provider?”. Birth 44 (2): 120-27.

Kumar, Rupali, Jeanne Farnan, Neel Shah, Andrew Levy, Mark Saathoff, and Vineet Arora. 2016. “GOTMeDS?: Development and Evaluation of an Interactive Module for Trainees on Reducing Patient’s Drug Costs”. Am J Med 129 (12): 1338-42.

Shah, Neel, and Don Dizon. 2009. “New-Generation Platinum Agents for Solid Tumors.”

Shah, Neel, Lisa Barroilhet, Ross Berkowitz, Donald Goldstein, and Neil Horowitz. 2012. “A Cost Analysis of First-Line Chemotherapy for Low-Risk Gestational Trophoblastic Neoplasia.”. The Journal of Reproductive Medicine 57 (5-6): 211-18.

Shah, Wright, Jonsdottir, Jorgensen, Einarrson, and Muto. 2011. “Comparing Robotic Hysterectomy With Alternate Operative Strategies for Endometrial Cancer: A Feasibility Analysis of Cost Equivalence from the Societal Perspective”. Gynecologic Oncology 120: S125-S126.